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Fused in Sarcoma (FUS) is a multifunctional RNA-/DNA-binding protein, which is
involved in the pathogenesis of the neurodegenerative disorders amyotrophic lateral
sclerosis (ALS) and frontotemporal dementia (FTD). A common hallmark of these
disorders is the abnormal accumulation of mutated FUS protein in the cytoplasm.
Under normal conditions FUS is confined to the nuclear compartment, in neurons,
however, additional somatodendritic localization can be observed. In this study, we
carefully analyzed the subcellular localization of endogenous FUS at synaptic sites
of hippocampal neurons which are among the most affected cell types in FTD with
FUS pathology. We could confirm a strong nuclear localization of FUS as well as its
prominent and widespread neuronal expression throughout the adult and developing
rat brain, particularly in the hippocampus, the cerebellum and the outer layers of the
cortex. Intriguingly, FUS was also consistently observed at synaptic sites as detected
by neuronal subcellular fractionation as well as by immunolabeling. To define a pre-
and/or postsynaptic localization of FUS, we employed super-resolution fluorescence
localization microscopy. FUS was found to be localized within the axon terminal in
close proximity to the presynaptic vesicle protein Synaptophysin1 and adjacent to
the active zone protein Bassoon, but well separated from the postsynaptic protein
PSD-95. Having shown the presynaptic localization of FUS in the nervous system, a
novel extranuclear role of FUS at neuronal contact sites has to be considered. Since
there is growing evidence that local presynaptic translation might also be an important
mechanism for plasticity, FUS – like the fragile X mental retardation protein FMRP –
might act as one of the presynaptic RNA-binding proteins regulating this machinery. Our
observation of presynaptic FUS should foster further investigations to determine its role
in neurodegenerative diseases such as ALS and FTD.
Keywords: FUS, RNA-binding proteins, local translation, amyotrophic lateral sclerosis, frontotemporal dementia,
super-resolution microscopy, STORM, synapse
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INTRODUCTION
During the last decade a growing number of RNA-binding
proteins has been identiﬁed as key players in the pathogenesis of
amyotrophic lateral sclerosis (ALS) and frontotemporal dementia
(FTD). Both diseases are now considered to be tightly linked
by common clinical as well as pathophysiological hallmarks.
ALS is a fatal, progressive neurodegenerative disorder which is
characterized by the selective demise of motor neurons in the
brain stem and spinal cord. FTD is the second most common
form of early onset dementia leading to aggravating changes
in personality and language. It is characterized by progressive
neuronal loss in frontal and temporal lobes. While many ALS
patients suﬀer from motor deﬁcits, the majority of FTD patients
develop cognitive and behavioral abnormalities. A common
hallmark of both neurodegenerative disorders is the presence
of pathologic protein deposits in the cytoplasm of aﬀected
neurons. In 2006, the RNA-binding protein TDP-43 encoded
by the TARDBP gene was identiﬁed as a major component
of ubiquitinated aggregates in ALS and FTD (Arai et al.,
2006; Neumann et al., 2006). Subsequently, several mutations
in the TARDBP gene have been reported as a primary cause
of ALS (Gitcho et al., 2008; Kabashi et al., 2008; Sreedharan
et al., 2008; Van Deerlin et al., 2008; Yokoseki et al., 2008).
The identiﬁcation of TDP-43 as an important protein in ALS
pathogenesis directly triggered the discovery of ALS and FTD
causing mutations in another RNA-/DNA-binding protein called
Fused in Sarcoma (FUS) (Kwiatkowski et al., 2009; Vance et al.,
2009; Blair et al., 2010; Damme et al., 2010). Similar to TDP-
43, FUS is a ribonuclear protein that is mainly located in the
nucleus but was found to shuttle between the nucleus and the
cytoplasm (Fujii and Takumi, 2005; Fujii et al., 2005). ALS-
linked mutations in FUS are mainly found in the NLS (nuclear
localization signal), giving rise to the abnormal presence of FUS
in the cytoplasm. Interestingly, increasing levels of cytoplasmic
FUS seem to be associated with a more aggressive disease
course (Dormann et al., 2010; Waibel et al., 2013). In FUS
associated FTD neuronal abnormalities are found in various
areas within the central nervous system (CNS) including the
hippocampus (Mackenzie et al., 2010). While pathologic FUS
aggregates in ALS only occur in the presence of FUS mutations,
no FUS mutations have been reported in FTD cases with FUS
pathology.
Since a clear correlation between abnormal subcellular
localization and disease progression is a unique feature of FUS
mediated neurodegeneration, it is pivotal to determine the exact
intracellular distribution of this protein in healthy neurons. FUS
may not just be a nuclear protein but is also transported along
neuronal processes to synapses in response to the speciﬁc and
tightly controlled demands of neuronal plasticity and activity.
For instance, FUS was also shown to be involved in nuclear
Abbreviations: COM, center of mass; DAPI, 4′,6-diamidino-2-phenylindole;
dSTORM, direct stochastic optical reconstruction microscopy; FTD,
frontotemporal dementia; FUS, Fused in Sarcoma; MAP2, microtubule-associated
protein 2; PBS, phosphate buﬀered saline; PSD, postsynaptic density; PSD-95,
postsynaptic density protein 95; SMLM, single molecule localization microscopy;
SYP1, Synaptophysin1; TDP-43, Tar DNA-binding protein 43.
messenger ribonucleic acid (mRNA) export and dendritic mRNA
transport (Fujii and Takumi, 2005; Fujii et al., 2005) and recently
its presence in granules along dendrites in the mouse and
human CNS including the spinal cord (Aoki et al., 2012) was
demonstrated. Cortical neurons from FUS mutant mice and
cultured hippocampal neurons from FUS deﬁcient mice display
disturbed spine maturation and excessive dendritic branching
(Fujii and Takumi, 2005; Fujii et al., 2005; Sephton et al.,
2014).
Intriguingly, besides their postsynaptic and/or dendritic
localization, mRNAs as well as RNA-binding proteins have also
been detected in the axonal compartment with a supposed
function in development- and activity-dependent plasticity of
the outgrowing neurite. Among those are fragile X mental
retardation protein (FMRP; Antar et al., 2006; Li et al., 2009),
survival motor neuron protein (SMN; Rossoll et al., 2003; Liu
et al., 2011), heterogeneous ribonucleoprotein R (hnRNP R;
Glinka et al., 2010) and TDP-43 (Godena et al., 2011; Fallini et al.,
2012) giving rise to the supposition that local mRNA translation
is also realized in presynaptic axon terminals (Hörnberg and
Holt, 2013). Axonal pathology is supposed to play a critical role
in motor neuron diseases (Jablonka et al., 2004).
An important open question is the precise subcellular
localization of FUS, which has thus far only been addressed
by light microscopy after immunolabeling. However, in general,
conventional ﬂuorescence microscopic analysis of proteins
localized to small subcellular compartments – like synapses –
are limited by the Abbe’s law to a resolution of 200–300 nm
even with confocal microscopes, restricting the accuracy of the
localization. Recent approaches in the ﬁeld of super-resolution
microscopy can overcome this barrier and provide a powerful
tool for life sciences to analyze functional structures such as
multiprotein complexes with typical diameters smaller than
50 nm (Betzig, 2015; Hell, 2015). In this study we used single
molecule localization microscopy (SMLM) (Rust et al., 2006;
Fölling et al., 2008; Gunkel et al., 2009) by using stochastic on/oﬀ
cycles of organic dye molecules, oftentimes also referred to as
direct stochastic optical reconstruction microscopy (dSTORM)
(Heilemann et al., 2008) to determine the exact intracellular
localization of FUS protein compared to post- and presynaptic
markers in hippocampal neurons. Previously, a related technique
has been applied to the localization of common synaptic proteins
(Dani et al., 2010) or to localize the neurotrophic receptor BDNF
(brain derived neurotrophic factor) in the synapse (Andreska
et al., 2014), thereby validating our approach. We found that FUS
is located in axon terminals in close apposition to the presynaptic
scaﬀolding protein Bassoon and co-localizing with the synaptic
vesicle protein Synaptophysin1 (SYP1).
MATERIALS AND METHODS
Animal Ethics Statement
All animal experiments were performed in compliance with the
guidelines for the welfare of experimental animals issued by
the Federal Government of Germany, the National Institutes of
Health and the Max Planck Society. The experiments in this
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study were approved by the review board of the Land Baden-
Württemberg, Permit Number Nr. O.103.
In Situ Hybridization
In situ hybridization was performed as described previously
(Proepper et al., 2011). Transcripts were detected with S35
labeled cDNA antisense oligonucleotides. FUS mRNA (bp
1067–1100) (GenBank:NM_001012137.1) was detected using the
oligonucleotide 5′-GTC GAT TGC AGC TTT AGC AGA AGG
TGG GTC ATC A-3′. Oligonucleotides were purchased from
MWG-Biotech (Ebersberg, Germany).
Immunohistochemistry
Immunolabeling of Rat Brain Slices for Conventional
Fluorescence Microcopy
Adult Sprague-Dawley rats were perfused and ﬁxed with 4%
paraformaldehyde and 0.5% glutaraldehyde diluted in PBS. After
ﬁxation, brains were cut into 80 µm sagittal slices using a
vibratome. The sections were then treated with 1% sodium
borohydride in PBS for 5 min, followed by a washing step in PBS.
For permeabilization, free-ﬂoating slices were incubated in 0.5%
Triton X-100 in PBS for 15 min. After additional three washing
steps the slices were blocked with 10% horse serum in PBS for
4 h at 4◦C. After blocking, primary antibodies were applied
overnight at 4◦C in 5% horse serum in PBS. The slices were
washed three times before the secondary antibodies were applied.
After incubation for 1 h at room temperature, the sections
were counterstained with 4′,6-diamidino-2-phenylindole (DAPI)
in PBS and washed another three times. For ﬂuorescence
microscopy the slices were mounted using Vecta Mount AQ
(Vector Laboratories, USA).
Immunoperoxidase Stainings
Whole rat brains at the indicated age were ﬁxed in Bouins
solution for 48 h and then embedded in paraﬃn. Sections were
then de-paraﬃnized and the endogenous peroxidase activity
was inhibited with a solution (10% methanol and 0.03% H2O2
in PBS). Afterwards, sections were washed three times with
PBS and permeabilized for 15 min with 0.5% Triton X-
100 in PBS. After 2 h of blocking with 2% bovine serum
albumin (BSA) in PBS the sections were incubated with
primary antibodies in PBS overnight at 4◦C. To visualize the
immunoreactivity the avidin-biotin-peroxidase technique was
used. Therefore biotin-labeled secondary antibodies diluted in
PBS with 0.5% BSA were added and incubated for 2 h at
room temperature. After this step, the sections were incubated
for another 2 h with a biotin peroxidase-streptavidin complex.
The peroxidase reactivity was detected by adding 0.02% DAB
(3,3′-Diaminobenzidine) in 50 mM Tris HCl pH 7.5. After
dehydration the sections were mounted with Entellan R© (Merck,
Germany).
Cultured Cells
Cell Lines
NIH3T3 cells (Deutsche Sammlung von Mikroorganismen
und Zellkulturen, DSMZ) were maintained in DMEM
(Dulbecco’s modiﬁed Eagle’s medium, Invitrogen, Germany),
supplemented with 10% FCS (fetal calf serum) and 100 units/ml
penicillin/streptomycin (Invitrogen). All cells were cultured in a
humidiﬁed atmosphere with 5% CO2 at 37◦C.
Culturing Rat Hippocampal Neurons
Hippocampal cell culture from rat embryos was performed as
previously described with minor modiﬁcations (Boeckers et al.,
2005). In brief, time mated adult pregnant Sprague-Dawley rats
were anesthetized and sacriﬁced by CO2 narcosis and subsequent
decapitation after suﬃcient hypnosis. Embryos were removed
from the uterus 18–19 days after mating. Brains were dissected
out from the embryos and placed into ice-cold HBSS (Hank’s
balanced salt solution). After isolation of the hippocampi, cells
were isolated by trypsin digestion and mechanical dissociation.
The hippocampal neurons were then plated on coverslips coated
with poly-L-lysine 0.05–0.1 mg/ml (Sigma–Aldrich, Germany)
on 12- or 24-well plates. Cells were grown in Neurobasal
medium supplemented with B27, L-glutamine (2 mM, gibco),
and 100 units/ml penicillin/streptomycin (Invitrogen). Cells
were grown at 37◦C in a humidiﬁed atmosphere containing
5% CO2. At 14 days after seeding cells were prepared for
immunocytochemistry.
Immunolabeling of Rat Hippocampal Neurons for
SMLM and Conventional Fluorescence Imaging
All described washing steps were performed with PBS (without
calcium and magnesium). Prior to the ﬁxation, cells were washed
4x with PBS. Subsequently, cells were incubated with pre-chilled
methanol for 5 min at −20◦C. The ﬁxation was followed by three
washing steps 5 min each.
Following steps were performed on a shaker. The samples
were prepared for antibody incubation with a buﬀer for blocking
and permeabilization (3% BSA, 0.1–0.3% Triton X-100 in
PBS) for min 2 h. Primary antibodies were diluted in the
blocking/permeabilization buﬀer and then cells were incubated
for 2–3 days at 4◦C (primary antibodies see Table 1 at the end
of section “Material and Methods”). Thereafter, coverslips were
washed 3x 30 min at room temperature and then incubated with
the secondary antibody in blocking/permeabilization buﬀer for
2–3 h at room temperature. Dye labeled secondary antibodies
were purchased from Invitrogen (derived from goat, Alexa Fluor R©
532 and 647 for SMLM, Alexa Fluor R© 488, 568, and 647 for
conventional ﬂuorescence microscopy, all diluted 1:750). Cells
were washed again 3x 30 min. Coverslips for super resolution
microscopy were then immediately used for analysis or for
longer storage cells were post-ﬁxated with methanol as described
above. For conventional imaging coverslips were brieﬂy washed
in deionized water after the last PBS washing step and mounted
in Vecta Mount containing DAPI in a dilution of 1:50.000.
Image Acquisition, Processing, and
Analysis
Conventional Fluorescence Microscopy – Image
Acquisition
Images were obtained with an upright ﬂuorescence microscope
(Zeiss Axioskop 2 and Zeiss Imager.Z1 with an apotome,
Zeiss, Germany). Pictures were taken with the Axiovison 4.7.1
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TABLE 1 | Primary antibodies.
Antibody RRID citation Dilution and Application
Bassoon(C)∗
Bassoon(N)∗
FUS
FUS
FUS
GAD65
GAPDH
Gephyrin
GFAP
GluA1
Homer1b/c
Synaptic Systems GmbH Cat# 141 003 RRID:AB_887697
Enzo Life Sciences Cat# ADI-VAM-PS003 RRID:AB_10618753
Proteintech Group Cat# 11570-1-AP RRID:AB_2247082
Santa Cruz Biotechnology Cat# sc-47711 RRID:AB_2105208
Sigma–Aldrich Cat# HPA008784 RRID:AB_1849181
Abcam Cat# ab85866 RRID:AB_1860505
Abcam Cat# ab9484 RRID:AB_307274
Synaptic Systems GmbH Cat# 147 011 RRID:AB_887717
Sigma–Aldrich Cat# G3893 RRID:AB_477010
Synaptic Systems Ca# 182 011 RRID:AB_1630258
Synaptic Systems GmbH Cat# 160022 RRID not available
1:500 (STORM)
1:500 (FI & STORM)
1:500 (FI on tissue sections)
1:400/1:200 (WB/DAB)
1:2000/1:500 (WB on NIH lysate/FI & STORM)
1:500 (FI)
1:1000 (WB)
1:500 (FI)
1:500 (FI)
1:500 (FI)
1:500 (STORM)
MAP2
MAP2
Sigma–Aldrich Cat# M4403 RRID not available
Synaptic Systems Cat# 188 004 RRID:AB_2138181
1:500 (FI on tissue sections)
1:500 (FI on cultured neurons)
PSD-95
PSD-95
SYP
SYP1
S-100 (ß)
VGLUT1
Abcam Cat# ab2723 RRID:AB_303248
Synaptic Systems GmbH Cat# 124 011 RRID:AB_10804286
Abcam Cat# ab14692 RRID:AB_301417
Synaptic Systems GmbH Cat# 101 004 RRID:AB_1210382
Sigma–Aldrich Cat# S2532 RRID:AB_477499
Synaptic Systems Cat# 135 304 RRID:AB_887878
1:500 (FI & STORM)
1:1000 (WB)
1:3000 (WB)
1:500 (STORM)
1:500 (FI)
1:500 (FI)
FI, conventional fluorescence imaging; DAB, 3,3′-Diaminobenzidine; WB, western blot. ∗(C) and (N), C-terminal or N-terminal antigenic epitopes, respectively.
software (Zeiss, Germany) and analyzed with ImageJ 1.46r
(National Institutes of Health of the United States; RRID:nif-
0000-30467).
Super-Resolved Single Molecule Localization
Microscopy – Image Acquisition
In order to obtain super-resolution 2D images of double labeled
synapses the SMLM technique dSTORM was used (primary
antibodies see Table 1). Experiments were performed on a
home built microscope. For illumination an objective-type TIRF
(total internal reﬂection ﬂuorescence) conﬁguration with an oil-
immersion objective (APO TIRF 60x, NA 1.49 Oil, Nikon) was
used. Three continuous-wave laser sources (640 and 402 nm,
Toptica Photonics, Germany, and 532 nm, Cobolt, Sweden) were
combined, controlled in intensity by an AOTF (acousto-optical
tunable ﬁlter; Gooch & Housego, United Kingdom) and used
for excitation and activation. Single molecule ﬂuorescence signals
were separated from activation and excitation light as well as
split into two detection channels by using appropriate dichroics
and emission ﬁlters (AHF analysentechnik, Tübingen, Germany)
and ﬁnally passed on to two halves of an EMCCD camera (iXon
897, Andor Technology, United Kingdom) with an eﬀective
pixel size of 132 nm. For dual color images a series of 30.000
images was acquired for the red channel, followed by another
30.000 images for the green channel, each taken at a frequency
of 46 Hz with typical laser intensities of 0.4–0.7 kW/cm2 for
excitation and 0–3 W/cm2 for activation. Microscope drift in
the axial, i.e., z-direction was automatically corrected during
image acquisition by a home built autofocus system. The xy-
drift was highly reduced by instrument design and was therefore
oftentimes negligible or could be compensated as described later.
For dSTORM imaging, cells were placed in a degassed
PBS imaging buﬀer containing 100 U/mL glucose oxidase,
400 U/mL catalase, 4% (wt/vol) glucose and 100 mM
cysteamine (all from Sigma–Aldrich, Schnelldorf, Germany) at
pH 7.5.
Single Molecule Localization Microscopy – Data
Processing
Acquired images were analyzed using custom written Matlab
software (MathWorks, Natick, MA, USA). In short, the image
series was background corrected by applying a running temporal
median ﬁltering (Hoogendoorn et al., 2014) with a window
size of 101 frames. The center position of ﬂuorescent spots
above a certain threshold was identiﬁed by their COM and
ﬁltered according to intensity, width and asymmetry criteria.
Fluorophore localizations were reconstructed in a pixel raster
of 10 nm and weighted with the intensity of the individual
localization. The second channel of a two color image was
transformed onto the ﬁrst channel according to a transformation
function obtained by imaging ﬂuorescent beads (TetraSpeck
Microspheres, life technologies, Darmstadt, Germany) in both
color channels. If xy-drift was not negligible it was compensated
by applying a redundant cross correlation algorithm to the
identiﬁed localizations (Wang et al., 2014). All presented super-
resolution reconstructed images were processed with a Gaussian
blur (sigma = 10 nm) to account for the localization precision.
Single Molecule Localization microscopy – Image
Analysis
Further analysis of reconstructed super-resolution images was
done with ImageJ under blinded conditions for statistical
evaluation. Synapses were identiﬁed manually in two color
images as co-localizing or near-by-localizing bar-like structures
and marked by a 300 nm wide line, perpendicular to the apparent
synaptic cleft. Intensities where averaged over the line width
yielding a one-dimensional intensity distribution along the line.
The COM is calculated by taking the arithmetic mean of the
labeled protein positions along the marked transsynaptic axis
weighted by their respective intensities. The distance of two
individual protein populations is then given by the distance of
the COMs of the two underlying intensity proﬁles (performed
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always on raw data without applying a Gaussian blur). The value
of many such single synapse measurements is then entered into
a histogram for the respective protein pairs. The reported mean
distance of two proteins results from taking into account only
the 40% of all synapses with the largest distances corresponding
to the largest entries in the respective histograms. This step was
introduced to reduce the ambiguity that arises from imaging a
three dimensional structure in only two dimensions. As therefore
the orientation of the synapses with respect to the imaging plane
is unknown, two clearly separate protein distributions (in 3D)
could appear in 2D as closely co-localizing distributions with
a false too small COM distance if the plane of the synaptic
cleft is parallel to the imaging plane. The more the synaptic
cleft is tilted out of the imaging plane the larger the measured
distance will be. By restricting the data to the largest measured
distances one ensures that mainly synapses whose synaptic
cleft is oriented (close to) perpendicular to the imaging plane
are counted and therefore more accurate measurements are
obtained. However, the reported results are not aﬀected by
the particular cut-oﬀ chosen (see Supplementary Figure S3 for
diﬀerent cut-oﬀs).
For all stainings including FUS also the COM in two
dimensions was determined, in contrast to the COM in one
dimension along a line as described before. For this purpose
synapses were identiﬁed in two color images manually as co-
localizing protein distributions and marked by a rectangle
enclosing these distributions. The COMs in two dimensions for
each protein population inside the rectangle and their respective
Euclidean distance were calculated. Results were again grouped
in a histogram as described above.
Protein Biochemistry
Tissue Fractionation
Subfractionation of rat brain tissue was performed as described
previously with some modiﬁcations (Distler et al., 2014). All
steps were performed at 4◦C or on ice. In brief, tissue was
homogenized in homogenization buﬀer (320 mM sucrose, 5 mM
HEPES, pH 7.4, protease inhibitor mixture (Roche, Germany). To
remove cell debris and nuclei the homogenate was centrifuged
for 10 min at 1.000 × g. The supernatant (S1) was centrifuged
for 20 min at 12.000 × g to obtain the soluble fraction (S2) and
the crude synaptosomal fraction (P2). For further fractionation,
P2 was resuspended in Tris buﬀer (320 mM sucrose, 5 mM
Tris/HCl pH 8.1) and centrifuged in a sucrose density gradient
(0.8 M/1.0M/1.2 M sucrose) for 2 h at 200.000 × g and 4◦C.
The myelin-enriched fraction (My) was obtained from the top
of the gradient, the light membranes (LM1) from the 0.8/1.0
interphase, and the puriﬁed synaptosomal fraction (Sy) from the
1.0 M/1.2 M interphase. The synaptosomes were then diluted in
ﬁve volumes of 1 mM Tris pH 8.1 and stirred on ice for 30 min
followed by another centrifugation step for 30 min at 33.000 × g.
The resulting pellet P3 was re-suspended in 5 mM Tris pH 8.1
and further fractionated by centrifugation on another sucrose
gradient (0.8 M/1.0 M/1.2 M sucrose) for 2 h at 200.000 × g. The
1.0 M/1.2 M interphase (containing the synaptic junctions, SJ)
was collected and resuspended in Triton buﬀer (320 mM sucrose,
5 mM Tris pH 8.1 and 0.5% Triton X-100). After stirring on ice
for 15 min another centrifugation step for 30 min at 33.000 × g
was performed resulting in a last pellet containing the one-Triton
extracted postsynaptic density (PSD) fraction.
Western Blot
Protein samples were diluted in SDS (sodium dodecyl sulfate)
loading buﬀer. Protein concentration was determined by
amido black assays. Samples were separated by SDS-PAGE
(polyacrylamide gel electrophoresis) and subsequently blotted
on PVDF membranes (GE Healthcare). Immunoreactivity of
primary antibodies (see Table 1) was detected using HRP-
conjugated secondary antibodies and the Pierce R© ECL detection
kit (Thermo Scientiﬁc).
RESULTS
FUS in Non-neuronal Cells
First, non-neuronal NIH3T3 cells were stained with an antibody
against the FUS N-terminus (diagram showing the epitope
is represented in Figure 1A, see also Table 1) using DAPI
as nuclear counterstain. FUS was expressed endogenously
and predominantly in the nucleus overlapping with DAPI
(Figure 1B). This FUS antibody has already been thoroughly
characterized (Munoz et al., 2009; Neumann et al., 2009; Urwin
et al., 2010; Aoki et al., 2012). In Western blot with NIH3T3 cell
lysates (mouse embryonic ﬁbroblast cell line) FUS was clearly
detectable as a 72 kilodalton (kDa) protein (Figure 1C).
Expression of FUS in the Rat CNS
Next, we analyzed FUS expression in the rat CNS using in situ
hybridization. We detected FUS mRNA in all brain areas,
especially in the cortex, the hippocampus, the granular cell layer
of the cerebellum and in the spinal cord. The sharply bound
lines in the hippocampus indicate a predominantly somatic
localization. These expression patterns could be observed at all
developmental stages investigated (Figure 1D).
Immunohistochemical DAB stainings of FUS in rat brain
sections conﬁrmed its broad expression throughout the rat brain
(Supplementary Figure S1). The expression analysis of FUS in
diﬀerent brain regions was performed in postnatal day P12
tissue, since the protein was strongly expressed at this age (see
Figures 1D,G). In accordance with the in situ hybridization
data, FUS was highly abundant in the cortex, the hippocampus
and the granular cell layer of the cerebellum (Figure 1E). For
expression patterns in various brain regions at diﬀerent neuronal
developmental steps see Supplementary Figure S1. Western blot
analysis of tissue lysates (homogenates at postnatal day P14)
from diﬀerent brain regions showed the abundant presence of
the protein throughout the CNS (Figure 1F). This analysis also
demonstrated remarkably high levels of FUS in the hippocampus.
Interestingly, we found comparably low levels of FUS in the spinal
cord. Next, we monitored closer the expression levels of FUS
in the hippocampus at distinct stages of postnatal development
(Figure 1G). The expression of FUS was sustained in the
hippocampus and during all investigated developmental stages
with highest levels at early developmental stages between P12
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FIGURE 1 | Continued
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FIGURE 1 | Continued
Fused in Sarcoma (FUS) expression in non-neuronal cells and in the
rat CNS. (A) Domain architecture of FUS and available epitope regions of
antibodies. Human FUS consists of 526 amino acids and comprises an
N-terminal QGSY rich region, a Glycine rich region, a RNA recognition motif,
two R/G rich domains, a zinc finger motif and a nuclear localization signal.
Q/G/S/Y = glutamine/glycine/serine/tyrosine, G-rich = glycine rich region,
RRM = RNA recognition motif, R/G = arginine/glycine, ZNF = zinc finger,
L = nuclear localization signal. (B) Immunostaining of FUS in NIH3T3 cells.
FUS is predominantly localized in the nuclear compartment counterstained
with DAPI. (C) Western blot of NIH lysate. FUS antibody detects a 72 kDa
band. (D) In situ hybridization of FUS during brain development. The mRNA is
mainly expressed in the cortex, the hippocampus and the cerebellum. No
obvious dendritic localization of FUS mRNA can be observed.
E19 = embryonic day 19, P9 = postnatal day 9. (E) DAB immunostainings of
FUS of a P12 rat brain. The observed expression pattern with high abundance
of the protein in the hippocampus, cortex and the granular cell layer of the
cerebellum is in good accordance to the expression pattern observed by
in situ hybridization experiments on P9. CB, cerebellum; HC, hippocampus;
CTX, cortex. (F) Western blot analysis of FUS expression in the rat CNS at
P12. FUS is abundant in all of the CNS regions investigated but with only a
weak signal in the spinal cord. The relatively highest concentration can be
observed in the hippocampus. OLF, olfactory bulb; SSC, somatosensory
cortex; MOC, motor cortex; HC, hippocampus; STR, striatum; DIE,
diencephalon; MES, mesencephalon; CB, cerebellum; BS, brain stem; SC,
spinal cord. GAPDH was used as a loading control. (G) Developmental stages
were examined in homogenates of the hippocampus at different time points.
In this specific brain region the expression of the protein is quite stable during
development with a peak at postnatal day P21. (H) Biochemical analysis of
subcellular fractions from adult rat whole brain. FUS was detected in all
subfractions including purified synaptosomes, synaptic junctions and the PSD
fraction. PSD-95 and SYP antibodies were used to control fractionation
procedure. PSD-95 shows a clear enrichment toward the PSD fraction, while
SYP was not detected in the PSD fraction indicating a high grade of PSD
purification. Ho, homogenate; P1, nuclear-enriched fraction; P2, crude
synaptosomes; S2, soluble fraction; My, myelin; LM1, light membranes; SY,
purified synaptosomes; SJ, synaptic junctions; PSD, postsynaptic density
fraction.
and P21 in relationship to the loading control protein GAPDH
(glyceraldehyde 3-phosphate dehydrogenase). When analyzing
subcellular fractions from whole brain, the protein was found in
the synaptosomal fraction (synaptic junctions) and in decreasing
amount toward the PSD fraction in which only a faint band
appeared (Figure 1H).
Subcellular Localization of FUS in
Cultured Hippocampal Cells
Next, we studied the subcellular localization of FUS in the
hippocampus CA1 (cornu ammonis) region (Figure 2A). To
that end, we performed immunohistochemical stainings on adult
rat brain sections. Besides its localization in the nuclei, FUS
was located in punctae alongside the MAP2 positive dendrites.
FUS punctae were additionally co-localizing with the presynaptic
scaﬀolding molecule Bassoon.
In line with our ﬁndings in brain sections of adult rats,
a clear localization of FUS in the nuclei as well as along
MAP2 positive dendrites was observed in cultured primary
hippocampal neurons (Figure 2B). A high proportion of FUS
clearly co-localized with the presynaptic marker Bassoon and
the postsynaptic density protein 95 (PSD-95), an excitatory
postsynaptic marker of glutamatergic synapses. Both markers
have been used for the following super-resolution studies.
Additionally, FUS co-localized to a lesser extent with the
inhibitory postsynaptic marker Gephyrin. Supplementary Figure
S2A demonstrates statistical evaluation of co-localizing FUS –
PSD-95 vs. FUS – Gephyrin punctae. Only 14% of all FUS
punctae in dendritic areas co-localize with Gephyrin whereas
65% can be found at PSD-95 accumulations. To further
substantiate our observation, we stained FUS with glutamatergic
pre- and postsynaptic markers VGLUT1 (vesicular glutamate
transporter 1) and GluA1 (glutamate AMPA receptor subunit
1), respectively, and the GABAergic presynaptic marker GAD65
(65 kDa subunit of glutamate decarboxylase) (Supplementary
Figure S2B). The results are in line with the previous observations
that FUS is predominantly associated with excitatory synapses.
Nuclear FUS was not only found in neurons but also in glial
cells marked with GFAP (glial ﬁbrillary acidic protein) and S-
100 (ß-subunit), in which as opposite to neurons FUS remained
nuclear (Mori et al., 2012) (Supplementary Figure S2C).
Super-Resolved Single Molecule
Localization Microscopy Reveals
Localization of FUS in Axonal Terminals
Conventional ﬂuorescence microscopy failed to resolve the exact
localization of FUS within hippocampal synapses. In order to
investigate the precise synaptic localization of FUS, a SMLM
setup (described in Super-Resolved Single Molecule Localization
Microscopy – Image Acquisition) with two excitation lasers
(532 and 647 nm) was used. Immunolabeled FUS and reference
synaptic proteins, namely SYP1, Bassoon and PSD-95, in cultured
hippocampal neurons of two diﬀerent preparations after 14 days
in vitro were analyzed in this approach. At this stage of in vitro
neuronal development it has been described that hippocampal
neurons contain morphologically mature synapses (Grabrucker
et al., 2009). In Figure 3 a reconstructed super-resolution image
of a co-staining of FUS and the postsynaptic marker PSD-95 is
depicted. The magniﬁcation shows a presumable dendritic area
with FUS opposed to PSD-95 signals.
Thereafter, to further analyze the precise localization of
FUS within hippocampal synapses we used several synaptic
markers as a reference. The aim was to identify the mean
position of the distribution of FUS proteins on either the
presynaptic side, the postsynaptic side or on both sides of the
synapse along the transsynaptic axis (Figure 4). To achieve
this, the intensity proﬁles of the protein distributions along
the presumed transsynaptic axis were investigated (described
in Single Molecule Localization microscopy – Image Analysis).
The mean distance of FUS relative to the presynaptic marker
Bassoon(N) (Figure 4D), as well as the mean distance
of FUS relative to the postsynaptic marker PSD-95 were
determined (Figure 4E). In addition, as control measurements,
we determined the mean distance of typical pre- and postsynaptic
proteins, as described below. The position of some of these
markers relative to the synaptic cleft had been determined
previously with super-resolution microscopy (Dani et al., 2010).
We determined the distance between the two presynpatic
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FIGURE 2 | Continued
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FIGURE 2 | Continued
Subcellular localization of FUS in hippocampal tissue and primary
neurons. (A) Immunofluorescence staining of the hippocampal CA1 region in
an adult rat brain. The lower row depicts magnifications of rectangles
indicated in the overview images above. FUS was found in the nuclei of
hippocampal neurons (arrowheads in middle row, left) and was additionally
localized in punctae alongside MAP2 positive dendrites (arrowheads in lower
row, left). FUS positive punctae co-localized with the synaptic marker
Bassoon (arrowheads in lower row, right). Scale bars represent 25 µm.
(B) Localization of endogenous FUS in 14 days in vitro primary hippocampal
neurons. Lower rows show magnifications as merged or single channels of
rectangles in the overview images of the respective neurons in the first row.
FUS could be clearly seen in the nucleus (overview images in red, nuclei
stained with DAPI) and in a punctuated pattern alongside MAP2 (blue) positive
dendrites. These punctae co-localized with the synaptic markers PSD-95 and
Bassoon (arrowheads) but less with the inhibitory postsynaptic marker
Gephyrin. Scale bars (white) represent 5 µm.
markers Bassoon(C) and SYP1 (Figure 4A), between the two
postsynaptic markers PSD-95 and Homer1b/c (Figure 4B),
as well as between the presynaptic marker Bassoon(C) and
the postsynaptic marker PSD-95 (Figure 4C). The determined
distances are in good agreement with the previously published
measurements.
The magniﬁcation in Figure 3 shows exemplary selections
(white boxes) used to obtain the intensity proﬁles along the
presumed transsynaptic axis. From histograms of the computed
COMs, the distance of the respective protein pairs was calculated
(see Single Molecule Localization microscopy – Image Analysis).
Figure 4 displays typical synapses of each marker combination
(left panel) and the corresponding raw intensity proﬁles along
the transsynaptic axis including the respective COMs depicted
as upright bars (middle panel). More than 150 synapses were
measured for each combination. The distances of all synapses are
grouped in a histogram in 10 nm steps to display the distribution
of all measurements (right panel). The following mean distance
values arise from imaging a three dimensional structure in two
dimensions as described before and result from only taking
into account 40% of all measured synapses with the highest
distance to select for synapses whose synaptic cleft is tilted out of
the imaging plane (for detailed explanation see Single Molecule
Localization microscopy – Image Analysis). The combination
of the two presynaptic proteins SYP1 and Bassoon(N) resulted
in a mean distance of 55 ± 3 nm (standard error of the
mean; n = 92 synapses) while Homer1b/c and PSD-95 showed
a distance of 63 ± 2 nm (n = 66 synapses). A pre- and a
postsynaptic marker combination with Bassoon(C) and PSD-95,
respectively, lead to a calculated mean distance of 107 ± 2 nm
(n= 117 synapses). Finally, FUS was analyzed versus Bassoon(N)
and PSD-95 with mean distances of 133 ± 3 nm (n = 185
synapses) and 237 ± 4 nm (n = 181 synapses), respectively.
The latter value highlights closer proximity of synaptic FUS to
the presynaptic marker Bassoon in contrast to the postsynaptic
marker PSD-95.
In another approach we co-stained FUS with SYP1 in 14 days
in vitro old neurons in order to investigate a localization of
FUS at synaptic vesicles (see Figure 5A). We observed the
highest co-localization of FUS with any of the tested synaptic
markers with an almost complete overlap of the overall areas
of labeled FUS and SYP1 proteins. Moreover, we ﬁnd that
ﬁrstly, both proteins seem to be less organized in bar-like
structures in a ‘side’ view on a synaptic contact. They are rather
disseminated in broader 2- and presumably 3-dimensional areas
which can be observed as broader signals when measuring along
the transsynaptic axis as described above (Figures 4A,D,E).
Secondly, no apparent cleft between FUS and SYP1 could be
observed, as between typical pre- and postsynaptic markers
(Figure 4C). In conclusion, neither the shape of the protein
distribution nor their relative positions allowed any inference
to the orientation of the transsynaptic axis. Therefore, we
determined the COMs in two dimensions in a rectangle that was
drawn around a presumable synaptic structure with co-localizing
FUS and SYP1 (described in Single Molecule Localization
microscopy – Image Analysis). We obtained a value of 52± 1 nm
(standard error of the mean; n = 122 synapses). However, it
should be noted that this value does not correspond to an actual
distance between the two proteins, but marks an upper estimate
which is mainly given by the experimental uncertainty due to
varying protein distributions of individual synapses and due to
localization imprecisions. The experimental uncertainties cancel
out if a clear separation between the positions of two protein
distribution is seen, however, experimental uncertainties add up
if the distributions of the two molecules coincide. To better
classify this result we also applied this method on the other co-
stainings including FUS (see above). FUS with the presynaptic
marker Bassoon yielded 133 ± 3 nm (n = 168 synapses) while
FUS with the PSD protein PSD-95 resulted in a mean distance
of 246 ± 4 nm (n = 164 synapses; see Figure 5B). As expected,
these results were minimally larger than those obtained with the
one dimensional measurement along the transsynaptic axis.
DISCUSSION
Main Findings
Our study on the diﬀerential expression of FUS in the rodent CNS
revealed three main ﬁndings: (1) We could conﬁrm and extend
the current knowledge of a mainly nuclear localization of FUS
and its prominent and widespread expression throughout the
adult and developing rat brain, particularly in the hippocampus,
the cerebellum and the outer layers of the cortex. (2) In
hippocampal neurons, FUS was also present in synaptic
compartments. (3) The SMLM analysis detected a presynaptic
localization for FUS ﬁlling the axonal bouton in a very close
proximity to synaptic vesicles.
FUS Localization in the Rodent Central
Nervous System
In line with previous reports, we found FUS to be strongly
localized in nuclei throughout the rat brain (Huang et al., 2010).
In particular, hippocampal, cerebellar and outer layer cortical
neurons were rich in the expression of the protein. In FUS-
associated FTD abnormalities of neurons are found in the cortex,
the hippocampus, in lower motor neurons and to a lesser extent
in the striatum, brainstem, and thalamus (Mackenzie et al.,
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FIGURE 3 | SMLM imaging of near-by co-localizing FUS and PSD-95 in hippocampal neurons. The upper image shows synapses of cultured hippocampal
cells with immunolabeled FUS (red) and PSD-95 (green). The white rectangles in the magnification (lower image) represent exemplary lines for measuring with a
defined width of 300 nm (short side of the rectangles) to receive an intensity profile along the transsynaptic axis. In this respect, the line spans the shortest distance
between the two signals which is perpendicular to the bar-like distribution of PSD-95 and the apparent synaptic cleft. This is to calculate the distance of the COMs of
each marker population. The scale bars (white) represent 1 µm.
2010). We chose the hippocampus as a model to study the
exact localization of FUS as (1) previous work on FUS had
mainly been done in hippocampal neurons (Belly et al., 2005;
Fujii et al., 2005; Wang et al., 2008), (2) we found the highest
expression of FUS in the hippocampus, and (3) for primary cell
culture we chose a point in time for analysis that represents
early developmental stages as we could observe FUS being highly
expressed in immature rat brains. Furthermore, the hippocampus
belongs to those brain regions aﬀected in FTD with FUS and
TDP-43 pathology (Mackenzie et al., 2010). When studying the
CA1 region in hippocampal sections we found that FUS, together
with a strong nuclear signal, showed a punctuated distribution
along dendrites. FUS punctae co-localized with the synaptic
marker Bassoon, suggesting a synaptic localization for FUS. In
addition, the similar observations could be conﬁrmed in primary
hippocampal cells with FUS being in close proximity to the
synaptic markers Bassoon and PSD-95. More detailed statistical
evaluation revealed a strong co-localization of FUS with PSD-
95, a protein which can be found at the postsynaptic side of
glutamatergic synapses. Only a small amount of synaptic FUS
co-localized with the inhibitory marker Gephyrin hinting toward
a role also at a subpopulation of inhibitory synapses. Further
studies will be needed to further investigate this association. As
opposed to neurons, in glial cells FUS was only nuclear and this
is in accordance with previous studies on human brain tissue
(Mori et al., 2012). Moreover, FUS seems to rather cluster not
directly at or beside the dendrite but at presumable dendritic
spine specializations in the vicinity of postsynaptic densities
of excitatory synapses (Boeckers, 2006). Taken together, these
experiments revealed a predominantly localization of FUS at
excitatory synapses of hippocampal neurons.
Intriguingly, subfractionation experiments using whole
brain tissue conﬁrmed that FUS is also present in cellular
compartments outside the nucleus including an enrichment
in the PSD fraction (Aoki et al., 2012). In our study, FUS was
clearly seen in the synaptosomal fraction that contains the
complete presynaptic terminal, including mitochondria and
synaptic vesicles, the postsynaptic membrane and the PSD. Only
a faint signal appeared in the PSD fraction. Both, biochemical
fractionations and conventional ﬂuorescence microscopy
are, however, methods that are not precise enough to clearly
distinguish between the pre- and postsynaptic subcompartments.
FUS is Localized in the Presynaptic
Compartment in Vicinity to Synaptic
Vesicles
We established super-resolved SMLM as an adequate method
to determine FUS localization within synapses. By co-staining
two pre- and two postsynaptic markers as well as a pre- and
postsynaptic marker in parallel we validated our concept of
measurement. Our ﬁndings are in good agreement with previous
studies that investigated the distance of synaptic markers in
sections of mouse olfactory bulbs (Dani et al., 2010). We
then co-stained (1) FUS with the presynaptic marker Bassoon
and (2) FUS with the postsynaptic marker PSD-95. The mean
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FIGURE 4 | Distance calculations of super-resolved synaptic protein populations. Reconstructed super-resolved single molecule localization microscopy
(SMLM) images of typical synapses (left), the corresponding raw intensity profiles without Gaussian blur (10 nm steps) along the transsynaptic axis (middle;
respective COMs depicted as upright bars) as well as histograms of computed distances with 10 nm steps (right) are shown for: (A) SYP1 and Bassoon(N),
(B) Homer1b/c and PSD-95, (C) Bassoon(C), and PSD-95, (D) FUS and Bassoon(N) and (E) FUS and PSD-95. The images are rotated with the transsynaptic axis in
a horizontal orientation. White bars represent 100 nm (pixel size 10 nm).
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FIGURE 5 | FUS is closely localized to synaptic vesicles. (A) The overview image shows synapses of cultured hippocampal neurons labeled with FUS (green)
and SYP1 (red). The synaptic area marked with a white rectangle is magnified. Most synapses seem to show a distribution with SYP1 surrounding FUS signals in the
‘center.’ White scale bars represent 1 µm in the overview and 100 nm in the magnification. (B) The counted numbers of measured distances of the 2D-COM
analysis are displayed as histograms with 10 nm steps.
distance between FUS and Bassoon was in the range of the
distance between Bassoon and PSD-95 leading to two diﬀerent
possibilities for the localization of FUS: toward the postsynaptic
side or more proximal than Bassoon in the direction of the
corresponding axon. The distance between FUS and PSD-95
was close to the sum of the distances of FUS/Bassoon and
Bassoon/PSD95, revealing a localization on the presynaptic side
more distant from the synaptic cleft than Bassoon. Amodel of the
proposed distribution of FUS in cultured hippocampal neurons
is depicted in Figure 6. The choice of a cutoﬀ that determines
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FIGURE 6 | Model of FUS distribution in relationship to synaptic markers in hippocampal excitatory neurons. The model displays an excitatory
glutamatergic synapse of hippocampal neurons. Bassoon (red) is a typical presynaptic marker while PSD-95 (green) marks postsynaptic densities of synapses using
glutamate as neurotransmitter. Co-stainings of FUS (blue) with both markers revealed a presynaptic localization proximal to Bassoon. This was performed by
determining the distances (gray arrows) with measured mean values as described in the text between the respective COMs of each protein population (crosshairs).
FUS and SYP1 (orange) are highly co-localizing.
which distances should be included into the analysis inﬂuences
the absolute values of mean distances, but it does not change the
conclusion of FUS being presynaptic.
Considering the obtained results of FUS being presynaptic
and with a distribution that was broad and rather in the
orientation of the synaptic axis – being reminiscent of the typical
cone shape, which appears triangular in 2D, of a presynaptic
terminal – we hypothesized not only a presynaptic presence
of FUS but more precisely a localization of FUS at synaptic
vesicles. These abundant structures in the presynapse with a
typical size of approximately 40 nm are at the resolution limit
of our localization data (Qu et al., 2009). Notably, in our super-
resolution images the co-localization of FUS and SYP1 appeared
to be highly independent of the presumable synapse orientation
since most synapses showed a good overlap of FUS and SYP1.
Intriguingly, when having a closer look on the distribution of
the two populations at a synapse, they seem to be separated on
a few tens of nm-scale. This can be due to several reasons: (1)
One explanation would be an antibody interference that might
become visible at this length scale. This is supported by the
observation that the labeling of FUS and SYP1 seems to behave
diﬀerent in other antibody combinations. (2) Another possibility
is that this distribution represents the real situation with little co-
localization on a nanoscale level. Further studies are required to
distinguish between these models but this is beyond the scope of
the current investigations.
Minor discrepancies in our study have to be discussed
when comparing the super-resolved SMLM results with the
biochemical subfractionation experiments. On the one hand, the
microscopy data indicated only a presynaptic localization. We
could not observe a weaker second ‘peak’ in the intensity proﬁles
in proximity to PSD-95 signals, however, a postsynaptic targeting
of FUS in low amounts cannot be ruled out. On the other hand,
the results from the biochemical experiments showed a weak
signal of FUS in rat PSD fraction that supposedly only contains
postsynaptic densities. Minor ‘contaminations’ of other cellular
compartments, especially from the presynapse, might also be
considered. Supposing a ‘true’ signal in the PSD fraction and
in parallel considering FUS being presynaptic in hippocampal
neurons, several reasons could explain such a discrepancy: (1)
FUS localization in neurons could be cell-type speciﬁc and
hence a subfractionation of whole brain lysate could lead to
a signal at the postsynaptic side. Contradictory results to the
study from Aoki et al. (2012) describing the presence of FUS
in higher amounts in the PSD containing fraction compared to
the presynaptic compartment from whole mouse brain lysate,
would be in line with this hypothesis. To date, it is not possible
to rule out a species-dependent FUS localization in the CNS
from diﬀerent rodents. (2) FUS expression and localization could
depend on the developmental age of neurons. Our results display
a development-dependent expression of the protein. For SMLM,
we analyzed cultured hippocampal neurons from embryos
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14 days after seeding. This stage resembles more a neuronal
maturation stage with ongoing synaptogenesis (Grabrucker et al.,
2009) while the biochemical analysis was performed on adult
brain material.
Summary and Outlook
Given its localization in synapses of the mature rat brain, FUS
may play an additional role in synapse formation or function.
FUS binds mRNAs encoding actin-related proteins, suggesting
a role in mRNA transport (Fujii and Takumi, 2005). In this
respect, the presynaptic localization of FUS in hippocampal
neurons adds another RNA-binding protein localized in the
presynaptic compartment. In 2003, SMN and also a member of
the hnRNP family (hnRNP R) were localized within axons of
motor neurons regulating most likely the translation of beta-actin
mRNA (Rossoll et al., 2003). Mutations in SMN are supposed to
be causative for spinal muscular atrophy (Jablonka and Sendtner,
2003). In addition, the fragile Xmental retardation protein FMRP,
that has been intensely characterized with respect to its role in
local translation within the postsynaptic compartment, was also
found in axons of hippocampal neurons (Antar et al., 2006).
Finally, TDP-43, another ALS related RNA-binding protein,
could be detected in the axonal compartment of motor neurons
(Fallini et al., 2012). Therefore, several RNA-binding proteins
are most likely part of a presynaptic machinery that regulates
local translation according to speciﬁc demands. Since SMN as
well as TDP-43 and FUS are known to be mutated in deﬁned
diseases of the muscular-skeletal system such as ALS and/or
in cortical degenerative disorders leading to FTD, an aberrant
function of these proteins at (pre-)synaptic sites has to be taken
into consideration with respect to a common pathophysiological
mechanism.
In summary, deﬁned mRNA-binding proteins are known to
be key player of neuronal mRNA production and transport
to ﬁne tune synaptic plasticity (Liu-Yesucevitz et al., 2011).
Our study gives insights into the distribution and expression
patterns of FUS in various neuronal systems and the primary
hippocampal cell culture model. We could not only conﬁrm
the nuclear localization of FUS during brain development but
showed an additional and precise localization of the protein at the
presynaptic terminal of hippocampal excitatory synapses. This
comprehensive analysis will foster further functional studies on
the role of FUS at synaptic sites in health and disease.
Moreover, we could show an almost complete co-localization
of FUS with a synaptic vesicle marker at the scale of the
resolution limit of our SMLM data. Further investigations will
be needed to describe this putative association on a structural
and biochemical level to deﬁne binding partners and presynaptic
sub-localizations. On a functional level it will be of enormous
interest to investigate the putative function of FUS in association
with synaptic vesicles. In this respect, it is most interesting that
TDP-43 pathology in individuals with sporadic ALS seems to
spread along synaptic contacts (Braak et al., 2013). On the same
lines, TDP-43 aggregates isolated from brain tissue of ALS and
FTD patients induced accumulation of the protein in a prion-like
manner in a cell line expressing TDP-43 in vitro (Nonaka et al.,
2013). Similarly, ALS-associated mutations in FUS were shown
to recruit wild-type FUS into pathologic aggregates (Nomura
et al., 2014). This mechanism of protein spreading was startlingly
also observed in ALS-associated mutations of SOD1 (superoxide
dismutase 1) and TDP-43 (Furukawa et al., 2011; Münch et al.,
2011; Maniecka and Polymenidou, 2015). Given the described
highly prion-like property of FUS, a prion replication mechanism
in pathological states should be discussed and could explain the
observed spreading behavior (King et al., 2012). In combination
with a putative interaction of FUS with synaptic vesicles, which
belong to a highly eﬀective signal transduction machinery, it
could mean that pathologic FUS might be able to surmount
the presynaptic membrane and with an unknown mechanism it
might enter subsequent neuronal cells.
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